Psilocybin Research for Depression

Course Description

This course delves into the global issue of depression, its impact on individuals worldwide, and the limitations of conventional treatments–in the context of the opportunities associated with psilocybin treatment. Participants will explore the prevalence of treatment-resistant depression, the recurrent nature of the condition, and the need for innovative approaches. Participants will learn about the history of clinical research with psilocybin, with particular focus on its use and efficacy in treating depression. Physiological, psychological, and spiritual dimensions of psilocybin's effects, along with the significance of therapy in optimizing outcomes, are discussed. This course covers the latest research findings, the science behind psilocybin's mechanisms of action, and the nuances of conducting clinical studies. The course concludes with a discussion of the potential implications for patients and practitioners of psilocybin-assisted therapy’s dissemination to a wider population.

Learning Objectives

At the end of this course, the participant will be able to:

• Identify key clinical research trials from psilocybin research in the treatment of depression

• Describe the clinical trial outcomes of psilocybin-assisted treatments for depression

• Explain the therapeutic rationale behind psilocybin-assisted therapy for depression

• Describe the proposed key mechanisms of action associated with psilocybin-assisted therapy for depression

• Identify the risks and benefits of psilocybin-assisted therapy for patients with depression compared to current interventions